N.M. Admin. Code § 16.19.20.67

Current through Register Vol. 35, No. 21, November 5, 2024
Section 16.19.20.67 - SCHEDULE III

Shall consist of drugs and other substances, by whatever official name, common or usual name designated listed in this section.

A.NARCOTIC DRUGS: Unless specifically exempt or unless listed in another schedule, any material, compound, mixture or preparation containing limited quantities of the following narcotic drugs, or any salts thereof.
(1) Not more than one and eight-tenths grams of codeine per 100 milliliters or not more than 90 milligrams per dosage unit, with an equal or greater quantity of an isoquinoline alkaloid of opium.
(2) Not more than one and eight-tenths grams of codeine per 100 milliliters or not more than 90 milligrams per dosage units, with one or more active nonnarcotic ingredients in recognized therapeutic amounts.
(3) Not more than 300 milligrams of dihydrocodeinone per 100 milliliters or not more than 15 milligrams per dosage unit, with a fourfold or greater quantity of an isoquinoline alkaloid of opium.
(4) Not more than 300 milligrams of dihydrocodeinone per 100 milliliters or not more than 15 milligrams per dosage unit, with one or more active, nonnarcotic ingredients in recognized therapeutic amounts.
(5) Not more than one and eight-tenths grams of dihydrocodeine per 100 milliliters or not more than 90 milligrams per dosage unit, with one or more active, nonnarcotic ingredients in recognized therapeutic amounts.
(6) Not more than 300 milligrams of ethylmorphine per 100 milliliters or not more than 15 milligrams per dosage unit, with one or more active, nonnarcotic ingredients in recognized therapeutic amounts.
(7) Not more than 500 milligrams of opium per 100 milliliters or per 100 grams or not more than 25 milligrams per dosage unit, with one or more active, nonnarcotic ingredients in recognized therapeutic amounts.
(8) Not more than 50 milligrams of morphine per 100 milliliters or per 100 grams, with one or more active, nonnarcotic ingredients in recognized therapeutic amounts.
B.STIMULANTS: Unless specifically exempt or unless listed in another schedule, any material, compound, mixture or preparation which contains any quantity of the following substances having a stimulant effect on the central nervous system.
(1) Those compounds, mixtures or preparations in dosage unit form containing any stimulant, amphetamine, phenmetrazine or methamphetamine previously exempt, for which the exemption was revoked by FDA Regulation Title 21, Part 308.13, and any other drug of the quantitative composition shown in that regulation for those drugs or which is the same except that it contains a lesser quantity of controlled substances.
(2) Benzphetamine
(3) Phendimetrazine
(4) Chlorphentermine
(5) Clortermine
C.DEPRESSANTS: Unless specifically exempt or unless listed in another schedule, any material, compound, mixture or preparation which contains any quantity of the following substances having a depressant effect on the central nervous system.
(1) Any compound, mixture or preparation containing:
(a) Amobarbital
(b) Secobarbital
(c) Pentobarbital
(d) Butalbital; or any salt thereof and one or more active medicinal ingredients which are not listed in any schedule.
(2) Any suppository dosage form containing:
(a) Amobarbital
(b) Secobarbital
(c) Pentobarbital; or any salt of any of these drugs approved by the FDA for marketing only as a suppository.
(3) Any substance which contains any quantity of a derivative of barbituric acid or any salt of a derivative of barbituric acid.
(4) Chlorhexadol
(5) Lysergic Acid
(6) Lysergic Acid Amide
(7) Methyprylon
(8) Sulfondiethylmethane
(9) Sulfonethylmethane
(10) Sulfonmethane
(11) Telazol; Tiletamine/zolazepam
(12) Ketamine Hydrochloride
(13) Any drug product containing gamma hydroxybutyric acid, including its salts, isomers, and salts of isomers, for which an application is approved under Section 505 of the Federal Food, Drug and Cosmetic Act.
(14) Embutramide
(15) Dronabinol (synthetic) in sesame oil and encapsulated in soft gelatin capsules in a drug product approved by the U.S. food and drug administration.
(16) Perampanel
D. MISCELLANEOUS:
(1) Nalorphine (a narcotic drug)
(2) Buprenorphine
(3) Clenbuterol
E.ANABOLIC STEROIDS: The term "anabolic steroid" means any drug or hormonal substance, chemically and pharmacologically related to testosterone (other than estrogens, progestins, and corticosteroids) that promotes muscle growth. Unless specifically exempt or unless listed in another schedule, any material, compound, mixture or preparation which contains any quantity of the following substances listed in this section:
(1) Boldenone
(2) Chloro testosterone
(3) Clostebol
(4) Dehydrochlormethyltestosterone
(5) Dihydrotestosterone
(6) Drostanolone
(7) Ethylestrenol
(8) Fluoxymesterone
(9) Formebolone
(10) Mestanolone
(11) Mesterolone
(12) Methandienone
(13) Methandranone
(14) Methandriol
(15) Methandrostenolone
(16) Methenolone
(17) Methyltrienolone
(18) Methyltestosterone
(19) Mibolerone
(20) Nandrolone
(21) Norbolethone
(22) Norethandrolone
(23) Oxandrolone
(24) Oxymesterone
(25) Oxymetholone
(26) Stanolone
(27) Sanozolol
(28) Testolactone
(29) Testosterone
(30) Trenbolone; and
(31) Any salt, ester, or isomer of a drug or substance described or listed in this paragraph, if that salt, ester, orisomer promotes muscle growth.
F. Exempt anabolic steroids: Compounds, mixtures, or preparations that contain an anabolic steroid that have been exempted by the board from Subsection E of 16.19.20.67 NMAC, schedule III to the same extent that the substance has been exempted from the application of the Federal Controlled Substance Act, if the substance is listed as an exempt anabolic steroid product under 21 C.F.R. Section 1308.34 and its subsequent amendments.

N.M. Admin. Code § 16.19.20.67

16.19.20.67 NMAC - Rp 16 NMAC 19.20.28(2), 07-15-02; A, 02-15-03; A, 06-30-05; A, 01-31-07; A, 01-15-08; A, 05-14-10; A, 06-28-14, Adopted by New Mexico Register, Volume XXIX, Issue 12, June 26, 2018, eff. 6/26/2018